| Literature DB >> 26738751 |
Eseosa T Ighodaro1,2, Erin L Abner2,3, David W Fardo2,4, Ai-Ling Lin2,5,6, Yuriko Katsumata4, Frederick A Schmitt2,7, Richard J Kryscio2,4,8, Gregory A Jicha2,7, Janna H Neltner9, Sarah E Monsell10, Walter A Kukull10,11, Debra K Moser12, Frank Appiah4, Adam D Bachstetter2, Linda J Van Eldik1,2, Peter T Nelson13,2,9.
Abstract
Risk factors and cognitive sequelae of brain arteriolosclerosis pathology are not fully understood. To address this, we used multimodal data from the National Alzheimer's Coordinating Center and Alzheimer's Disease Neuroimaging Initiative data sets. Previous studies showed evidence of distinct neurodegenerative disease outcomes and clinical-pathological correlations in the "oldest-old" compared to younger cohorts. Therefore, using the National Alzheimer's Coordinating Center data set, we analyzed clinical and neuropathological data from two groups according to ages at death: < 80 years (n = 1008) and ≥80 years (n = 1382). In both age groups, severe brain arteriolosclerosis was associated with worse performances on global cognition tests. Hypertension (but not diabetes) was a brain arteriolosclerosis risk factor in the younger group. In the ≥ 80 years age at death group, an ABCC9 gene variant (rs704180), previously associated with aging-related hippocampal sclerosis, was also associated with brain arteriolosclerosis. A post-hoc arterial spin labeling neuroimaging experiment indicated that ABCC9 genotype is associated with cerebral blood flow impairment; in a convenience sample from Alzheimer's Disease Neuroimaging Initiative (n = 15, homozygous individuals), non-risk genotype carriers showed higher global cerebral blood flow compared to risk genotype carriers. We conclude that brain arteriolosclerosis is associated with altered cognitive status and a novel vascular genetic risk factor.Entities:
Keywords: Arteriosclerosis; CVD; HS-Aging; TDP-43; VCID
Mesh:
Substances:
Year: 2016 PMID: 26738751 PMCID: PMC5363738 DOI: 10.1177/0271678X15621574
Source DB: PubMed Journal: J Cereb Blood Flow Metab ISSN: 0271-678X Impact factor: 6.200